3,6-dichlorobenzo[b]thiophene-2-carboxylic acid alleviates ulcerative colitis by suppressing mammalian target of rapamycin complex 1 activation and regulating intestinal microbiota

BACKGROUND: 3,6-dichlorobenzo[b]thiophene-2-carboxylic acid (BT2) is a benzothiophene carboxylate derivative that can suppress the catabolism of branched-chain amino acid (BCAA)-associated mammalian target of rapamycin complex 1 (mTORC1) activation. Previous studies have demonstrated the therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Qiong-Zi, Wei, Peng, Zhang, Jun-Zhi, Liu, Tong-Tong, Shi, Kun-Qun, Liu, Huan-Huan, Zhang, Jing-Wei, Liu, Shi-Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782837/
https://www.ncbi.nlm.nih.gov/pubmed/36569276
http://dx.doi.org/10.3748/wjg.v28.i46.6522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782837/
https://www.ncbi.nlm.nih.gov/pubmed/36569276
http://dx.doi.org/10.3748/wjg.v28.i46.6522

Ejemplares similares